Zobrazeno 1 - 10
of 241
pro vyhledávání: '"Pascal Bonnabry"'
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The COVID-19 pandemic strained healthcare systems immensely as of 2020. Switzerland’s hospital pharmacies’ responses during the first wave were surveyed with a view to improving the quality of pharmaceutical management in futu
Externí odkaz:
https://doaj.org/article/8fde3950317b4fedb127ec37f5c0c7c1
Autor:
Laurence Schumacher, Salim Senhaji, Birgit Andrea Gartner, Laurent Carrez, Arnaud Dupuis, Pascal Bonnabry, Nicolas Widmer
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Purpose Assess whether full-scale simulation exercises improved hospital pharmacies’ disaster preparedness. Methods Swiss hospital pharmacies performed successive full-scale simulation exercises at least four months apart. An interprofessi
Externí odkaz:
https://doaj.org/article/0036dc0d9cbd42d0924a374fa9f0b644
Autor:
Christian Skalafouris, Jean-Luc Reny, Jérôme Stirnemann, Olivier Grosgurin, François Eggimann, Damien Grauser, Daniel Teixeira, Megane Jermini, Christel Bruggmann, Pascal Bonnabry, Bertrand Guignard
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via computerized order entry systems, and clinical pharmacists performing medication reviews as par
Externí odkaz:
https://doaj.org/article/b72f801600ee476382dcf3c5f81de7ff
Autor:
Sandrine von Grünigen, Ludivine Falaschi, Nicolas Guichard, Sandrine Fleury-Souverain, Antoine Geissbühler, Pascal Bonnabry
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1480-1489 (2021)
PURPOSEChemotherapies are considered high-risk drugs for patient and staff safety. Considering the rising burden of cancer and the increasing use of chemotherapy drugs in low- and middle-income countries (LMICs), promoting continuous improvements in
Externí odkaz:
https://doaj.org/article/bbd4764fb25c43bf93d923f5ff7f7c34
Autor:
Pascal Bonnabry, Bertrand Guignard, Bernard Cerutti, Katherine S Blondon, Beatriz Santos, Elisabeth Van Gessel, Claudine Backes, Sophie Locher, Delesha Carpenter, Marie P Schneider
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objective The number of patients with chronic diseases and subsequent visits to various healthcare professionals has been rising over the past decades, exposing patients to potential risks of receiving conflicting medication information. This study a
Externí odkaz:
https://doaj.org/article/ed77810457c6494fbe2f736ccbb813f3
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
The pharmaceutical technology unit of the Geneva University Hospitals played a significant role in the fight against COVID-19 through four different missions: (1) providing enough hydroalcoholic solution at the peak of the pandemic; (2) facing supply
Externí odkaz:
https://doaj.org/article/6e7ef64ef0bd4aa5b95e3dd6eb1ea383
Autor:
Thomas Rudolf von Rohr, Roberta de Luca, Pascal Bonnabry, Riccardo E. Pfister, Caroline Fonzo-Christe
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 2526 (2021)
AIMS OF THE STUDY To develop a screening tool to optimise neonatal drug prescription, which is often based on low-quality evidence. METHODS Neonatal pharmacotherapy recommendations were identified by literature review and synthesised into NeoChe
Externí odkaz:
https://doaj.org/article/adcd54e159634bd68bbfa5aa11a9fac7
Autor:
Nicolas Simon, Nicolas Guichard, Pascal Odou, Bertrand Decaudin, Pascal Bonnabry, Sandrine Fleury-Souverain
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235131 (2020)
BackgroundResidual contamination by intravenous conventional antineoplastic drugs (ICAD) is still a daily issue in hospital facilities. This study aimed to compare the efficiency (EffQ) of 4 different solutions to remove 23 widely used ICADs from sur
Externí odkaz:
https://doaj.org/article/b516cfd6a0ba4b56a82283deaf519d8b
Autor:
Klara M. Posfay-Barbe, Henri Baudet, Valérie A. McLin, Paloma Parvex, Hassib Chehade, Christophe Combescure, Pascal Bonnabry, Caroline Fonzo-Christe
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 4950 (2019)
BACKGROUND Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences. AIM The purpose of our
Externí odkaz:
https://doaj.org/article/b4c96de2e253476283ef29d1d0cb5cfd
Autor:
Anne-Laure Blanc, Thierry Fumeaux, Jérôme Stirnemann, Elise Dupuis Lozeron, Aimad Ourhamoune, Jules Desmeules, Pierre Chopard, Arnaud Perrier, Nicolas Schaad, Pascal Bonnabry
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219348 (2019)
BackgroundIdentifying patients at high risk of hospital preventable readmission is an essential step towards selecting those who might benefit from specific transitional interventions.ObjectiveDerive and validate a predictive risk score for potential
Externí odkaz:
https://doaj.org/article/9b95f8d03dad40218c68a9fa858a6205